LAG3 and liver cancer: Recent studies have recognized that the overexpression of immune checkpoints, such as PD‐L1, CTLA4, and LAG3, is associated with poor prognosis in liver cancer,27, 28 which is consistent with our result of the Lnc_high group having poor DFS and OS.